Non-pharmacological interventions for caregivers ... - Update Software
Non-pharmacological interventions for caregivers ... - Update Software
Non-pharmacological interventions for caregivers ... - Update Software
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
mental demands, autonomy in decision-making, training opportunities,<br />
availability of professional support, etc) or <strong>interventions</strong><br />
that target both caregiver and care-giving working conditions on<br />
a range of outcomes.<br />
Description of the condition<br />
An increasing number of studies have found an association between<br />
stress in in<strong>for</strong>mal <strong>caregivers</strong> and immune dysregulation<br />
(Gouin 2008), an increased risk of mortality (Schulz 1999),<br />
elevated blood pressure (King 1994), impaired wound healing<br />
(Kiecolt-Glaser 1995), increased risk of coronary heart disease (Lee<br />
2003) and poorer cognitive function among women who provide<br />
care to their disabled or ill spouses (Lee 2004). The hypothesis<br />
is that when the demands placed on the in<strong>for</strong>mal caregiver are at<br />
variance with the needs, expectations and capacity of the caregiver,<br />
this stress can predispose the caregiver to ill health.<br />
Description of the intervention<br />
We are interested in any <strong>interventions</strong> targeted towards the caregiver<br />
or the care-giving working conditions, or <strong>interventions</strong> that<br />
target the combination of caregiver and care-giving working conditions.<br />
How the intervention might work<br />
These <strong>interventions</strong> might work to reduce the care-giving demands<br />
through:<br />
• changing the knowledge, beliefs, attitudes or behaviours of<br />
the caregiver; or<br />
• temporarily reducing or removing the caregiver’s<br />
responsibility <strong>for</strong> the stroke survivor; or<br />
• addressing ongoing psychological and social problems.<br />
Why it is important to do this review<br />
Given that <strong>caregivers</strong> provide a substantial amount of the overall<br />
care delivered to stroke survivors and are likely to be at risk of<br />
adverse health outcomes, it would be useful <strong>for</strong> healthcare professionals,<br />
in<strong>for</strong>mal <strong>caregivers</strong>, as well as those responsible <strong>for</strong> the<br />
disbursement of health and social care resources, to have easy access<br />
to this in<strong>for</strong>mation to prevent further associated morbidity.<br />
Furthermore, aspects of the health of <strong>caregivers</strong> are addressed in<br />
several Cochrane Reviews (Ellis 2010; Smith 2008); however, the<br />
<strong>caregivers</strong> are not the primary focus of any review.<br />
O B J E C T I V E S<br />
The objective of this review was to provide the most reliable summary<br />
of the effect of <strong>interventions</strong> targeted towards in<strong>for</strong>mal <strong>caregivers</strong><br />
of stroke survivors or targeted towards in<strong>for</strong>mal <strong>caregivers</strong><br />
and the care recipient (the stroke survivor). The specific questions<br />
were as follows.<br />
1. What are the effects of <strong>interventions</strong> targeted towards<br />
in<strong>for</strong>mal <strong>caregivers</strong> of stroke survivors?<br />
2. Is the evidence of benefit greater in any pre-defined<br />
subgroup?<br />
M E T H O D S<br />
Criteria <strong>for</strong> considering studies <strong>for</strong> this review<br />
Types of studies<br />
<strong>Non</strong>-<strong>pharmacological</strong> <strong>interventions</strong> <strong>for</strong> <strong>caregivers</strong> of stroke survivors (Review)<br />
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.<br />
We sought all truly randomised controlled trials (RCT) of non<strong>pharmacological</strong><br />
<strong>interventions</strong> targeted towards in<strong>for</strong>mal <strong>caregivers</strong><br />
of stroke survivors with the aim of either: changing knowledge,<br />
beliefs, attitude or behaviours of the in<strong>for</strong>mal caregiver, or<br />
temporarily reducing/removing the caregiver’s responsibility <strong>for</strong><br />
the stroke survivor. We excluded studies which included stroke<br />
survivors and <strong>caregivers</strong> if the stroke survivors were the primary<br />
target of the intervention.<br />
Types of participants<br />
We included trials that recruited in<strong>for</strong>mal <strong>caregivers</strong> of stroke patients.<br />
A definition of an in<strong>for</strong>mal caregiver is ’a person of any<br />
age who provides one or more hours of unpaid help and support<br />
per week to a stroke survivor’. However, <strong>for</strong> the purpose of this<br />
review, we accepted the investigators’ definition. We excluded trials<br />
of mixed aetiology if the percentage of stroke patients was less<br />
than 80%.<br />
Types of <strong>interventions</strong><br />
The review focused on trials of non-<strong>pharmacological</strong> <strong>interventions</strong>,<br />
compared with no care or routine care that has the following<br />
features:<br />
• delivered to an in<strong>for</strong>mal caregiver of a stroke survivor;<br />
• delivered to an in<strong>for</strong>mal caregiver and a stroke survivor as a<br />
dyad: that is, both in<strong>for</strong>mal caregiver and stroke survivor are<br />
randomised; and<br />
• where there is an intention to have an impact on <strong>caregivers</strong>’<br />
knowledge, beliefs, attitude or behaviour.<br />
Trials of non-<strong>pharmacological</strong> <strong>interventions</strong> where there is an intention<br />
to reduce or remove the responsibility <strong>for</strong> care-giving, <strong>for</strong><br />
3